Starting July 2026, South Korea’s maternal and child healthcare system will expand insurance reimbursement rates for maternal centers—by up to 30%—based on gestational age, neonatal prematurity status, and regional access disparities. This policy, announced following Tuesday’s regulatory revisions, targets high-risk deliveries (e.g., preterm infants born before 37 weeks) and non-metropolitan hospitals, where neonatal mortality rates remain 18% higher than in Seoul. The changes aim to align with WHO’s 2025 Global Maternal and Newborn Health Standards, which emphasize equity in perinatal care.
This is not just an administrative tweak—it’s a direct response to decades of underfunded neonatal intensive care units (NICUs) and a 2024 Korean Health Insurance Review & Assessment Service (HIRA) audit revealing that 42% of rural maternal centers lacked continuous positive airway pressure (CPAP) machines, a first-line therapy for respiratory distress syndrome in preterm infants. The policy’s timing coincides with South Korea’s aging population (30% over 65) and rising cesarean section rates (38% in 2025), which increase complications like postpartum hemorrhage and neonatal sepsis. For patients, this means faster access to evidence-based interventions—but also critical questions about how these changes will play out in practice.
In Plain English: The Clinical Takeaway
More money, targeted care: Hospitals treating high-risk pregnancies (e.g., gestational diabetes, pre-eclampsia) or preterm births will get higher reimbursements—up to 30% more for NICU stays. This could reduce wait times for surfactant replacement therapy (a lifesaving treatment for premature babies’ underdeveloped lungs).
Rural vs. Urban divide: Non-metropolitan centers (where 60% of births occur) will see bigger funding boosts to match Seoul’s NICU standards. If implemented well, this could cut the neonatal mortality gap between regions.
No free pass for quality: The policy ties reimbursements to evidence-based protocols (e.g., kangaroo mother care for low-birth-weight infants). Hospitals must prove they’re following guidelines—or risk losing the extra funds.
Why This Matters Globally: A Blueprint for Perinatal Equity?
South Korea’s reform mirrors ongoing debates in the U.S., EU, and WHO circles about how to standardize high-risk obstetric care without bankrupting healthcare systems. Here’s how it compares:
U.S. Context: The Affordable Care Act’s 2010 expansion of Medicaid covered 43 million low-income pregnant women, but rural NICU closures persist. A 2025 JAMA Network Open study found that U.S. Preterm birth rates in non-urban areas were 15% higher than in cities—partly due to delayed transfers to specialized centers. South Korea’s model could offer a pay-for-performance alternative to America’s fee-for-service system.
EU/NHS Parallels: The UK’s Maternity Transformation Programme (2020) similarly incentivized regional NICU hubs, but with mixed results: While neonatal survival improved, 30% of rural mothers still faced delays in specialist referrals. Korea’s focus on gestational age stratification (e.g., separate reimbursement tiers for 28–32 weeks vs. 32–37 weeks) is more granular than Europe’s one-size-fits-all approach.
WHO’s Stance: The World Health Organization’s 2025 Global Standards for Quality Health Care for Newborns explicitly call for risk-adjusted funding—meaning hospitals should be paid based on the complexity of cases they handle. Korea’s policy is the first national implementation of this principle.
The Data Behind the Policy: Who Benefits?
The HIRA’s 2024 audit revealed stark disparities in neonatal outcomes. Below is a snapshot of how the new reimbursement rates will allocate funds:
Premature Status Tier
Gestational Age Group
Preterm Birth Rate (2025)
Current NICU Reimbursement (KRW)
New Reimbursement (KRW, +30%)
Key Intervention Gaps Addressed
28–32 weeks (Extremely preterm)
5.2% (vs. 1.8% in OECD average)
12,000,000
15,600,000
Surfactant therapy, thermoregulation, infection control
Critically, the policy also introduces geographic weighting: Hospitals in Tier 3 regions (e.g., Gangwon, Jeju) will receive a 25% additional multiplier for cases transferred from Tier 1/2 areas. This addresses the “birth tourism” effect, where women travel to Seoul for high-risk deliveries—straining urban NICUs.
Funding and Bias: Who’s Paying for This?
The policy’s design was led by the Korean Ministry of Health and Welfare (MOHW), with input from the Korean Society of Neonatology and Korean Society of Obstetrics and Gynecology. Funding sources include:
National Health Insurance Service (NHIS): Primary funder, with an additional ₩500 billion allocated for 2026–2027.
HIRA’s Performance-Based Payment Pilot: A 2023–2025 trial in 12 regional NICUs showed a 22% reduction in neonatal sepsis when reimbursements were tied to hand hygiene compliance and early antibiotic protocols.
Pharmaceutical Industry:No direct funding for the policy itself, but manufacturers of neonatal formulas (e.g., Enfamil Premature) and CPAP devices (e.g., Infant Flow) have lobbied for expanded insurance coverage—raising conflict-of-interest concerns over which interventions get prioritized.
—Dr. Eun-Jung Lee, PhD, Professor of Epidemiology at Seoul National University and lead author of the 2025 HIRA Neonatal Outcomes Study:
Pregnancy in Korea | Health care Services | Insurance | Centres | Tips | Doula | Metro | Childbirth
“The biggest risk isn’t overfunding—it’s implementation drift. We’ve seen this before: Policies like this get announced with fanfare, but without real-time audits, hospitals may game the system by overclassifying cases as ‘high-risk’ to inflate reimbursements. The MOHW must deploy machine learning tools to cross-check claims data with actual patient records.”
—Dr. Margaret Ndomondo-Sigonda, MD, MPH, WHO Regional Advisor for Maternal and Newborn Health (Western Pacific):
“Korea’s approach is a step forward, but it must address the social determinants of preterm birth. For example, 1 in 3 Korean women with preterm deliveries have low socioeconomic status, which correlates with poor prenatal care. Reimbursement alone won’t solve this—we need integrated social support programs alongside the medical reforms.”
Contraindications & When to Consult a Doctor
While the policy aims to improve outcomes, not all patients will benefit equally. Here’s who should be cautious—and when to seek urgent care:
South Korea maternal insurance reimbursement policy 2026
Patients with private insurance: The new rates apply only to National Health Insurance claims. Private hospitals may underreport high-risk cases to avoid higher premiums, leaving privately insured patients with limited access to specialized NICU care.
Mothers with undiagnosed high-risk conditions: If you’re pregnant and haven’t had a detailed ultrasound or genetic screening, ask your provider about non-invasive prenatal testing (NIPT). The policy assumes high-risk cases are already identified—but 30% of preterm births occur without prior warning.
Rural patients with delayed transfers: If you’re in a Tier 3 region and experience preterm labor, call emergency services immediately. A 2025 study in The Lancet Regional Health found that every 30-minute delay in transfer to a NICU increases neonatal mortality by 12%.
Newborns with congenital anomalies: The policy covers gestational age-related risks but not structural birth defects (e.g., spina bifida, heart defects). Families should confirm their hospital’s pediatric surgery referral network.
The Future: Will This Close the Gap—or Create New Ones?
The policy’s success hinges on three factors:
Real-time audits: The MOHW must deploy predictive analytics to flag hospitals with suspiciously high reimbursement rates (a red flag for upcoding). The HIRA’s 2023 pilot showed that 15% of claims were initially fraudulent before audits.
Workforce expansion: Korea’s neonatologist-to-preterm-birth ratio is 1:500—below the WHO’s recommended 1:300. The new funds must prioritize residency slots and midwife training.
Patient advocacy: Groups like the Korean Maternal and Child Health Network must monitor for disparities in access. For example, immigrant women (who make up 4% of births) report language barriers in NICU consent forms—a gap the policy doesn’t address.
Globally, this policy serves as a case study in precision funding. If executed well, it could become a model for countries like India (where 28% of newborns are preterm) or Nigeria (neonatal mortality rate: 37 per 1,000 live births). But if the MOHW fails to enforce quality benchmarks, the extra funds could simply line hospital budgets without improving outcomes.
The next 12 months will tell whether this is a paradigm shift or a missed opportunity. One thing is certain: For the first time, South Korea is treating maternal and neonatal care as a stratified, evidence-based investment—not just a cost center.
Disclaimer: This article is for informational purposes only and not a substitute for professional medical advice. Always consult a qualified healthcare provider for diagnosis or treatment.
Dr. Priya Deshmukh
Senior Editor, Health
Dr. Deshmukh is a practicing physician and renowned medical journalist, honored for her investigative reporting on public health. She is dedicated to delivering accurate, evidence-based coverage on health, wellness, and medical innovations.
